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Silver nanoparticles have antibacterial properties, but their use has been a cause for concern 
because they persist in the environment. Here, we show that lignin nanoparticles infused with silver 
ions and coated with a cationic polyelectrolyte layer form a biodegradable and green alternative to 
silver nanoparticles. The polyelectrolyte layer promotes the adhesion of the particles to bacterial 
cell membranes and, together with silver ions, can kill a broad spectrum of bacteria, including 
Escherichia coli, Pseudomonas aeruginosa and quaternary-amine-resistant Ralstonia sp. Ion 
depletion studies have shown that the bioactivity of these nanoparticles is time-limited because of 
the desorption of silver ions. High-throughput bioactivity screening did not reveal increased toxicity 
of the particles when compared to an equivalent mass of metallic silver nanoparticles or silver 
nitrate solution. Our results demonstrate that the application of green chemistry principles may 
allow the synthesis of nanoparticles with biodegradable cores that have higher antimicrobial 
activity and smaller environmental impact than metallic silver nanoparticles. 
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Silver nanoparticles (AgNPs) possess broad-spectrum antimicrobial, antifungal1 and antiviral2 activity. 
They are shown to be effective in killing prokaryotic microorganisms like Escherichia coli (E.coli)3, 
Pseudomonas aeruginosa (P. aeruginosa)4, and antibiotic-resistant bacterial strains5. AgNPs are believed 
to interfere with essential bacterial cell functions upon contact6, although the exact mechanism of the 
antimicrobial effect is still subject to debate7. However, after their intended use, the waste nanoparticles are 
hard to recover or deactivate in solid-waste incineration plants8 or wastewater treatment systems9. While 
processes such as sulfidation may over time convert the AgNPs to less hazardous form10, the long exposure 
of their core in the environment11,12 and prolonged activity after their intended application13 may adversely 
affect multiple ecosystems14,15. For this reason, AgNPs have been recognized as potential environmental 
hazard16, and their use is beginning to be regulated in many countries17,18. 
The problems mentioned above can be mitigated by using green chemistry principles19 at the stage of 
nanoparticle design. So far, these principles have been applied to AgNP synthesis20,21 by using safer solvents 
and auxiliaries22, which , however, does not solve the problem of persistent nanoparticle waste. We 
demonstrate that an environmentally-friendly solvent synthesis can be combined with other green chemistry 
principles to make a class of sustainable nanoparticles with short term activity as substitutes for 
antimicrobial metallic AgNPs. Since the antimicrobial action of AgNPs stems from the localized emission 
of Ag+ ions at the microbes' cell walls23, we envisaged that it is not necessary for the whole nanoparticle to 
be made of silver, as its metallic core would remain unused and may eventually be released in the 
environment. Instead, we replaced the AgNPs with cores of degradable common biopolymer, which can be 
easily precipitated into nanoparticles of desired size by using environmentally-friendly solvents. The 
degradable cores are infused with minimal amount of Ag+ ions needed for bactericidal action and are 
surface-functionalized to increase affinity towards targeted (bio)substrates. Such nanoparticles would 
rapidly lose their post-utilization activity and biodegrade in the environment after disposal (Fig. 1). 
The design of antimicrobial nanoparticles requires understanding of their interactions with the intended 
target (microbe) to enhance silver ion antimicrobial efficiency as a way to reduce active material loading. 
Nanoparticle interactions with living organisms are complex24 and subject to intensive ongoing research25. 
While the potency of AgNPs depends on a number of nanoparticle-specific26,27 and bacteria-specific 
properties28, their surface charge is likely to be the primary facilitator of their antimicrobial action29. 
Cationic AgNPs are electrostatically attracted to negatively-charged bacterial cell membranes. Their 
adhesion to the cell surface increases the local silver ion concentration10. The Ag+ ions released at the cell 
walls may disrupt their membrane integrity30 and can affect the cells through multiple mechanisms, 
ultimately leading to their death31,32. In order to enhance the adhesion of these silver ion nano-carriers to 
the microbial cell surface, we coated the silver-infused nanoparticle cores with a layer of cationic 
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polyelectrolyte. The results demonstrate that such engineered nanoparticles could be as efficient as their 
AgNPs analogs, but have time-limited antimicrobial activity because of depletion of the bioactive Ag+ ions. 
 
Figure 1 | Schematics of the general use cycle and principle of bactericidal action of the environmentally-benign 
lignin-core nanoparticles (EbNPs) compared to the presently used silver nanoparticles (AgNPs). a, General 
mechanism of antimicrobial action of common AgNPs via release of Ag+ ions, which continues post utilization. 
b, Antimicrobial action mechanism of Ag+ ion-infused EbNPs with cationic polyelectrolyte coating, which facilitates 
electrostatic attraction between the EbNPs and the negatively charged cell walls. In contrast to AgNPs, EbNPs are 
depleted of silver ions during application, minimizing their post-utilization activity. c, TEM micrograph of as-
synthesized EbNPs in the size range of 40 to 70 nm. d, Confocal microscopy image of EbNPs with polyelectrolyte 
coating adhering to the cell membrane of E. coli. 
 
Fabrication and characterization of EbNPs 
We choose lignin, one of the most abundant and underutilized biopolymers in nature33, as a benign particle 
core material. The used lignin was Indulin AT, which is extracted from biomass as by-product of the Kraft 
pulping processes34. It is soluble in alkali solutions, but insoluble in neutral and acid conditions and has 
high absorbance capacity for heavy metal ions in environmental remediation processes35,36. We showed 
earlier how biopolymer micro- and nanoparticles can be synthesized via an entirely water-based, solvent 
free, pH-drop flash precipitation method37,38. A similar pH-drop flash precipitation in ethylene glycol 
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solution can be applied to synthesize negatively-charged pH-stable Indulin AT lignin nanoparticles of 
controlled sizes38. The nanoparticles could be synthesized in a broad size range (Fig. 2a); the ones used as 
EbNP precursors after dialysis had a mean hydrodynamic diameter of 84 ± 5 nm as measured by Dynamic 
Light Scattering and a zeta potential of -33 ± 1 mV (see supplementary information (SI) for measurement 
details). 
In the next step, the lignin nanoparticle cores were infused with Ag+ ions at pH 5.0 by using an aqueous 
solution of AgNO3 as silver source. The IAT lignin has several functional groups, e.g. carboxylic, thiol, 
phenolic and aliphatic hydroxyl groups (see Table S1 in SI) that can serve as binding sites for silver ions35,36. 
Previous studies indicated that the particles are porous38,39, which would increase the total available surface 
area for silver ion loading and could potentially increase their degradation rate in the environment after 
disposal38. The interaction of Ag+ ions with the particles was investigated by characterizing the adsorption 
equilibria (Fig. 2b, see also Fig. S1 and Table S2 in SI) and the Ag+ desorption kinetics (Fig. 2c). These 
data taken together indicate the presence of high and low energy binding sites, as not all adsorbed Ag+ ions 
are released after 48h (Fig. 2c). The net binding of Ag+ ions onto the EbNPs could be modeled on the basis 
of a modified Langmuir adsorption isotherm Γ(𝑐) = Γmax 𝐾 𝑐 /(1 + 𝐾 𝑐) +  Γ1, where Γ and c are the 
respective surface and bulk equilibrium concentrations of silver ions; Γmax is the maximum surface loading 
for weakly bound silver ions, K is the adsorption constant, which relates to the Ag+ binding energy to the 
particles40, and Γ1 is the adsorption of strongly bound silver ions in the high affinity region in mg/g of 
EbNPs. The least square fitting of the experimental data in Fig. 2b at value of Γ1 = 1.4 Ag
+ per gram obtained 
from desorption data (see below) resulted in Γmax = 9.17 Ag
+ mg/g and K = 0.11 L/mg Ag+ (see Table S3 
in SI for details).  
The Ag+ release profile of nanoparticles infused with 4.9 Ag+ mg/g in pure water is plotted in Figure 
2c (see Table S4 in SI for Ag+ ion adsorption measurements). The silver ions adsorbed in the high affinity 
region ( 35% of the initial concentration) may not be released readily. However the weakly bound Ag+ 
ions adsorbed in the low affinity region are released during application. The release data can be fitted with 
exponential decay curve, offset by the strongly bound silver ions in the high affinity region (Fig. 2c), Γ(𝑡) =
 Γ1 +  Γ0 e
−𝑡/τ, where Γ0 is the weakly bound silver load, t is the time and τ the characteristic decay time. 
The least square fit resulted in values of  Γ1 = 1.4 Ag
+ mg/g and τ = 6.2 h (see Table S3 in SI for fitting 
details). In summary, the data indicate that more than 95 % of the silver ions in the low affinity region are 
released within the first 24 h, which is consistent with their anticipated application time. 
After silver ion infusion, EbNPs-Ag+ are electrostatically stabilized and have a negative zeta-potential 
of -32 mV ± 1 mV (see SI for measurement details). In the last step, the surface charge of the particles was 
reversed by the adsorption of a cationic polyelectrolyte, polydiallyldimethylammonium chloride (PDAC), 
which may also delay slightly the release of silver ions from the particles (Fig. S2 in SI) due to formation 
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of electrostatic barrier for their release. Stable EbNPs 0.05 wt% with positive surface potential could be 
fabricated at weight ratio of PDAC/Indulin AT of 0.20 or higher as shown in Fig. 2d. The TEM image in 
Fig. 1c displays nanosized non-spherical clusters with sizes below 70 nm. The accumulation of these 
cationic EbNPs on negatively charged E.coli was visualized by confocal microscopy (Fig. 1d). The ionic 
silver in these PDAC-coated, Ag+-loaded EbNPs (EbNPs-Ag+-PDAC) could be readily released via 
desorption near the cell walls, which could explain their strong antimicrobial efficacy reported below. 
 
Figure 2 | Synthesis and characterization of environmentally-benign nanoparticles. a, Size control - diameter of 
EbNPs as a function of HNO3 added during the flash precipitation. The diameter of EbNPs increases with addition of 
larger amounts of HNO3. b, Amount of Ag+ ions adsorbed on the EbNPs as a function of equilibrium silver ion 
concentration. The data are fitted on basis of a modified Langmuir adsorption isotherm (see text). c, Amount of Ag+ 
ions retaining in the EbNPs in silver ion depletion test as a function of time (initial load of 3.5 Ag+ mg/g). The particles 
release more than 95 % of the weakly bound Ag+ within the first 24 h. d, Surface charge modification - diameter and 
zeta potential of EbNPs as a function of PDAC added. PDAC / Indulin AT weight ratios between 0.10 and 0.15 result 
in aggregation of EbNPs. PDAC to Indulin AT wt% ratios of 0.20 or higher result in stable suspensions of PDAC-
 6 
coated EbNPs with positive surface charge. Error bars represent the standard deviation of corresponding experimental 
values. 
 
Antimicrobial activity of EbNPs 
The antimicrobial activity of EbNPs-Ag+-PDAC nanoparticles was evaluated within 6 h after their 
preparation. Quantitative antimicrobial tests were performed on gram-negative E. coli BL21(DE3), a 
common testing bacteria related to pathogenic E.coli such as O157:H7, which has been genetically modified 
not to secrete toxin, and P. aeruginosa (ATCC 15442), a highly adaptive pathogen used in standardized 
disinfectant testing in the food industry41. Antimicrobial testing on a quaternary amine-resistant 
Ralstonia sp. was also performed to distinguish the antimicrobial effect of Ag+ ions from PDAC controls, 
and to evaluate the post-utilization activity of silver-depleted EbNPs. Finally, qualitative antimicrobial tests 
were performed on Staphylococcus epidermidis (S. epidermidis), strain PCI 1200 (ATCC 12228) to 
evaluate the activity of the particles towards gram-positive bacteria. The testing was carried out according 
to a standardized exposure protocol (Fig. S3) at three contact times, 1 min, 30 min and 24 h. The activity 
of each sample was determined by counting the colony-forming units (CFU) and comparing the CFUs on 
test and reference plates (Fig. S4). The maximal antimicrobial reduction efficiency of 100% was reached 
when no CFUs were detectable on the test plate. The EbNPs efficiency was compared against positively 
charged branched polyethyleneimine-coated AgNPs (BPEI-AgNPs) and AgNO3 solutions. BPEI-AgNPs 
have a surface charge similar to the functionalized EbNPs and are known for their excellent antimicrobial 
activity compared to other common AgNPs29,42. The BPEI-AgNPs were synthesized via photoreduction of 
AgNO3 solution43 and had a hydrodynamic diameter of 20 ± 10 nm. Six different samples of BPEI-AgNPs 
and AgNO3 solutions with Ag+ ion equivalent concentrations ranging from 5 to 100 Ag+ mg/L (ppm) were 
investigated. 
The CFU reduction efficiencies of the samples in E. coli tests are compared as a function of the silver 
content by mass in Fig. 3a and 3b (see also Fig. S5 and Table S5 in SI). The EbNPs-Ag+-PDAC exhibited 
strong antimicrobial activity after 1 min exposure, while the corresponding nanoparticle-free supernatant 
showed no observable effect. The supernatant showed some CFU reduction after 30 minutes, which can be 
explained by residual amounts of unbound PDAC or silver. The conventional BPEI-AgNPs and AgNO3 
solutions were less effective after 1 min, but after 30 min contact time reached 100% microbicidal efficiency 
at 50 mg/L Ag+ equivalent. EbNPs-Ag+ without PDAC coating did not result in significant CFU reduction 
(5%), which may be attributed to their negative surface charge reducing the particle adhesion to the bacteria. 
However, EbNPs-PDAC without silver also showed strong CFU growth suppression, which may be 
attributed to the antimicrobial effect of the quaternary amine coating (note also that PDAC control reached 
100% bacteria reduction after 30 min). 
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The antimicrobial efficiencies data on P. aeruginosa after 30 min are compared in Fig. 3c. The EbNPs-
Ag+-PDAC sample resulted in strong CFU reduction at 5 mg/L Ag+ equivalent (this sample reached 100% 
reduction after 24 h, see Fig. S6 in SI). Interestingly, BPEI-AgNPs did not exhibit observable antimicrobial 
activity even at 100 mg/L Ag+ equivalent. AgNO3 solutions were inactive up to 40 mg/L Ag+ equivalent 
and exhibited low CFU reduction at 60 mg/L Ag+. The control PDAC solutions at 0.02 wt% did not exhibit 
observable CFU reduction after 30 min contact time, and the PDAC solutions at 0.04 wt%, double the 
amount used in EbNPs-Ag+-PDAC sample, exhibited strong CFU reduction. However, again the EbNPs-
Ag+-PDAC performed best in terms of antimicrobial efficiency, demonstrating higher efficiency than 
AgNO3 solution containing 12× more Ag+, and BPEI-AgNPs containing 20× higher Ag equivalent. These 
EbNPs were also 100% effective against the gram-positive bacteria S. epidermidis (see Table S7 in SI). 
The CFU reduction data on PDAC-resistant Ralstonia sp. after 30 min contact time are compared in 
Fig. 3d. The EbNPs-Ag+-PDAC, AgNO3 solutions, and BPEI-AgNPs all resulted in 99%+ CFU reduction 
at  5 mg/L Ag+ equivalent. The EbNPs-Ag+ without PDAC coating reached moderate CFU reduction at 
10 mg/L Ag+ after 30 minutes. PDAC solution at 0.04 wt% did not show any CFU reduction even after 
24 h of contact (see Fig. S7 and Table S6 in SI). Similarly, lignin-only EbNP controls did not result in any 
observable CFU reduction in all tests; on the contrary, they promoted CFU growth to some extent (see Fig. 
S8 in SI). 
In summary, comparing all active agents tested in terms of broad-spectrum antimicrobial efficiency, 
we establish that EbNPs-Ag+-PDAC proved most effective against four types of gram-positive and gram-
negative bacteria. These EbNP particles also outperformed the common AgNPs and AgNO3 solutions on 
E. coli and P. aeruginosa while using at least 10× lower Ag+ equivalent concentrations. The EbNPs-Ag+-
PDAC also outperformed PDAC on Ralstonia sp. The high activity of EbNPs-Ag+-PDAC likely stems from 
the combination of the antimicrobial properties of Ag+ ions and the PDAC coating, especially on cells that 
are sensitive to quaternary amines. However, for bacteria resistant to charged amines, such as the Ralstonia 
sp., the effect of EbNPs-Ag+-PDAC is a direct result of the bactericidal activity of silver ions. 
Finally, the post-utilization activity of EbNPs-Ag+-PDAC depleted from silver ions was evaluated on 
PDAC-resistant Ralstonia sp. We simulated the post-application depletion process of silver from EbNPs-
Ag+-PDAC, which were originally infused with 5 mg/L Ag+ ions, by dialysis in DI water for 24 h. This led 
to silver ion desorption similar to the one that would occur if the particles were disposed in environmental 
water. The residual silver ion content in these dialyzed samples was determined to be 0.89 mg/L Ag+ ions 
using Inductively-Coupled Plasma Optical Emission Spectroscopy (ICP-OES), which translates to 18 % of 
Ag+ remaining bound on the particles and is in good correspondence with the release kinetics studies 
described above. The silver-depleted EbNPs-Ag+-PDAC sample exhibited moderate CFU reduction of 
66 % on Ralstonia sp. at 24 h contact time, but showed bacterial film formation due to excessive cell 
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multiplication at 96 h, while the non-silver-depleted EbNPs-Ag+-PDAC control had 100% CFU reduction 
at 24 h (see Fig. S8 in SI). This result indicates that EbNPs-Ag+-PDAC nanoparticles would lose their 
antimicrobial activity due to Ag+ ion depletion when exposed to the environment. The lignin cores depleted 
from silver ions would in turn be further degraded by the microbial flora present in the environment. 
 
 
Figure 3 | Quantification of Colony Forming Unit reduction efficiency as a function of mg/L Ag+ equivalent of 
EbNPs and control samples on E. coli, P. aeruginosa, and Ralstonia sp. a, E. coli test – 1 min contact time. The 
fully functionalized sample is EbNPs-Ag+-PDAC. It is compared to a number of controls, including the centrifuged 
supernatant solution from the sample (“snat”), EbNPs without Ag+, PDAC polyelectrolyte solution, AgNO3 solution 
and BPEI-coated AgNPs. EbNPs-Ag+-PDAC achieved the highest CFU reduction of all samples with the smallest 
amount of silver. b, E. coli test – 30 min contact time. Note that in addition to silver ion-releasing EbNPs and AgNPs, 
the cationic polyelectrolyte PDAC is highly efficient. c, P. aeruginosa test – 30 min contact time. EbNPs-Ag+-PDAC 
and PDAC turn out to be much more efficient than common AgNPs and AgNO3 solution. d, PDAC-resistant Ralstonia 
test – 30 min contact time. For these bacteria EbNPs-Ag+-PDAC, BPEI-AgNPs and AgNO3 solutions outperformed 
PDAC samples. Note that EbNPs-Ag+-PDAC is the only sample that is consistently efficient at very low Ag+ loading. 
The experiments were performed three times, and the error bars represent the range of average values. 
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Figure 4 | Heat map of the bioactivity of EbNPs-Ag+-PDAC, EbNPs, AgNO3 (aq) and AgNPs, based on ToxCast 
mammalian cell and zebrafish embryo screening assays. The heat map reports on activities in assays (see Fig. S11 
in SI for detailed assay labeling) at either the Lowest Effective Concentration (LEC), concentration at 50% of 
maximum activity (AC50), or Benchmark Dose (BMD). The color coding relates to the sample mass concentrations 
where significant changes are registered as follows: blue and red colors both indicate measureable deviations in the 
assays from neutral activities, which are shown in yellow and arbitrarily set on 100,000. Deeper red indicate increases 
starting at lower concentrations than light red, deeper blue indicate decreases starting at lower concentrations than 
light blue. The heat-map shows that based on total sample mass concentrations, AgNPs and AgNO3(aq) had very 
similar profiles, and affected more assays (blue and red) than EbNPs and EbNPs-Ag+-PDAC. 
 
High-throughput screening of EbNPs bioactivity 
The biological activity and potential toxicity hazards of the particles were investigated in a comprehensive 
testing by the U.S. EPA’s ToxCast program44 protocols as described in the Methods. The 156 biological 
endpoints are described in the Methods. The aggregate assay targets are divided into ten biological function 
groups (see Fig. S9 in SI), namely zebrafish development toxicity, acute inflammation, cell cytotoxicity, 
cell proliferation, cellular stress modulation, immune response, nuclear receptor activation, tissue 
remodeling modulation, and vascular biology modulation. The testing results are summarized in the 
bioactivity “heat map” in Fig. 4. The data indicate that EbNPs and EbNPs-Ag+-PDAC had response profiles 
more similar to each other than to AgNP or AgNO3(aq). When evaluated on a total mass basis at Lowest 
Effective Concentration (LEC) > 0.1 μg/mL, they also affected fewer biological endpoints in all biological 
functional groups than AgNPs or AgNO3 (aq) (see Fig. S9 in SI). At LEC < 0.1 μg/mL the results show the 
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same trend, although some endpoints (e.g. in immune response) were affected at lower Ag+ ion 
concentration by EbNPs-Ag+-PDAC than by AgNPs. When evaluated by equivalent silver ion 
concentration, EbNPs-Ag+-PDAC appeared to affect zebrafish embryos at lower silver content than AgNPs 
(see Fig. S10 in SI). 
Overall, the bioactivity screening results show that the lignin-only EbNPs without Ag+ loading and the 
EbNPs-Ag+-PDAC interfered with fewer biological pathways than the AgNO3(aq) and AgNPs. Thus, it 
could be expected that the EbNPs-Ag+-PDAC would also have a much smaller environmental impact in 
terms of amount of silver released, as they would contain much less silver by mass than the common AgNPs 
in antimicrobial application scenarios relating to higher silver "atom economy"19. Their impact is likely to 
be minimized further as the EbNPs, unlike the persistent AgNPs, can rapidly lose their activity due to Ag+ 
ion depletion in the environment or wastewater, followed by natural pathways for the neutralization of the 
minimal amount of ionic silver45. The EbNPs surface modifier, PDAC, commonly used as a primary organic 
coagulant in waste water treatment46, is also likely to be readily neutralized once it interacts with naturally 
occurring biopolymers47. The lignin NPs depleted of Ag+ and PDAC would biodegrade similarly to lignin 
from plant biomass48,49. The EbNPs are also likely be more readily degraded and removed than common 
AgNPs in waste water treatment systems or in waste incineration plants. 
 
Conclusions 
We report a class of antimicrobial nanoparticles with biodegradable cores (from Indulin AT lignin), loaded 
with Ag+ ions and coated with cationic polyelectrolyte PDAC. The EbNPs-Ag+-PDAC exhibit broad 
spectrum biocide action and are capable of neutralizing common gram-negative and gram-positive human 
pathogens as well as quaternary amine-resistant bacteria, while using 10× less silver when compared with 
conventional BPEI-AgNPs and AgNO3 aqueous solution. The PDAC coating, which boosts their adhesion 
to microbial cell membranes, may have some antibacterial activity on its own; however, both EbNP controls 
without PDAC or without Ag+ ion loading demonstrated much lower antimicrobial efficiencies, indicating 
that both agents act synergistically. The array of high-throughput screening tests on mammalian cells and 
zebrafish embryos indicate that the EbNPs have decreased impact on the majority of biological endpoints, 
when compared with AgNPs and AgNO3 by total mass. In addition, the EbNPs-Ag+-PDAC showed time-
limited antimicrobial action since they can lose their residual silver ions by post-utilization dilution in water. 
We expect that the overall environmental impact of EbNPs-Ag+-PDAC is likely to be significantly lower 
when compared to AgNPs, however, more research and long-term testing in realistic real-world conditions 
(such as in water containing salts, surfactants and pollutants) would be needed to fully validate these claims. 
In more general plan, these environmentally-benign nanoengineering results illustrate how green chemistry 
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principles including atom economy, use of renewable feedstocks, and design for degradation can be applied 
to design more sustainable nanomaterials with increased activity and decreased environmental footprint. 
 
 
Methods 
Synthesis of Ag+-infused Indulin AT nanoparticles with PDAC coating. Native Indulin AT lignin nanoparticles 
were synthesized in ethylene glycol similarly to the method described earlier38 and detailed in the SI. The native 
Indulin AT nanoparticles were subsequently functionalized with silver ions from AgNO3 in aqueous solution. The 
Ag+-infused EbNPs were coated with PDAC by rapidly mixing 1:1 by volume of EbNP suspension with PDAC 
solution. 
 
Cell culture and microbial testing. E. coli BL21(DE3), P. aeruginosa (ATCC 15442), and S. epidermidis (ATCC 
12228) bacteria were grown in nutrient broth. The subsequent dilution series was performed with nutrient broth and 
the bacteria were stored at 4°C before exposure to active agents. PDAC resistant Ralstonia sp. were stored in freshly 
prepared PDAC 0.02 wt% solutions (for bacteria isolation and analysis see SI). AgNO3 testing solutions were prepared 
from a 1000 mg/L Ag+ reference standard. The target concentrations of Ag+ in mg/L for antimicrobial testing were 
reached by diluting the reference standard with Millipore water. The schematics in Fig. S3 in SI describe the protocol 
for antimicrobial testing. 200 µL of each active agent was placed into separate low retention centrifuge tubes. 100 µL 
of PBS buffer (in Ralstonia test 100 µL of DI water instead of PBS buffer) was added to each tube to baseline the 
ionic strength, and to adjust the pH value to 7. Finally, 100 µL of bacteria, Ecoli or P. aeruginosa, suspension with 
approximately 1000 to 4400 CFU/mL in nutrient broth (Ralstonia sp. in PDAC 0.02 wt% solution), was added. The 
samples were continuously vortexed. After the bacteria were exposed to the active agent for a given time, e.g. 30 
minutes, the survival rate of the bacteria was determined by plating 100 µL of each sample evenly distributed on 
Luria-Bertani agar plates. The procedure was repeated after various exposure time. After the plating procedure, the 
Petri dishes were sealed and incubated upside down for 48 h at 37 °C. 
 
Depletion of silver-infused EbNPs. The EbNPs-Ag+ samples for the depletion study were depleted from Ag+ in 0.5 
mL Slide-A-Lyzer MINI Dialysis Devices by dialysis against 13.6 mL Millipore water between 5 min and 48 h. The 
sample EbNPs-Ag+-PDAC (20 mL) for bioactivity testing was depleted from Ag+ using dialysis tubing against 380 
mL of DI water for 24 h without exchanging the dialysis water. The equilibrated samples were collected and their 
silver contents were measured with Inductively Coupled Plasma Mass Spectroscopy (ICP-MS) and Optical Emission 
Spectroscopy (ICP-OES) (for experimental description see SI). 
 
Biological activity and toxicity hazards tests. EbNPs-Ag+-PDAC, EbNPs, AgNO3, and AgNPs of 15 nm diameter 
(ENPRA NM300)50 were screened for 156 endpoints in five cell-based platforms used in ToxCast, the U.S. EPA’s 
chemical testing and prioritization program44. The bioactivity assays used human primary cell (co)culture and cell 
lines, rat primary hepatocytes, and developing zebrafish embryos with a diverse range of toxicity early responses and 
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phenotype endpoints. Gold (Au) nanoparticles, included as relatively inert nanomaterial controls, and Ag 
microparticles affected very few assays (Fig. S9f and S9g in SI), indicating that particles having the feature of being 
nanosized (AuNP), or containing Ag alone, do not exhibit broad or high bioactivity. 
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